Vocalbeats.AI Achieves ISO/IEC 42001 Certification, Reinforcing Responsible AI Governance Publication of the Number of Shares Composing the Share Capital and of the Total Number of Voting Rights as of March 31, 2023
Nicox SA Société anonyme with a registered capital of € 50,156,698 Head Office: DRAKKAR D 2405 route…
Rookout Makes Snapshots the Fourth Pillar of Observability, Capturing Deep Code-Level Insights for Developers
Traditional observability telemetry consists of metrics, logs, and traces. Snapshots capture code-level, context-rich pictures of…
LevaData Introduces New Industry-Leading Capabilities for Spend Intelligence and Lead Time Visibility
The company’s most impactful platform release to date provides a major boost to companies looking…
nOps Announces New Innovations in Its Comprehensive Solution for Enterprises
San Francisco, California–(Newsfile Corp. – April 3, 2023) – nOps continues to revolutionize the AWS…
Coinweb has Closed $2 Million Fundraising Round from SAVA Investment Management
HONG KONG, Apr 3, 2023 – (ACN Newswire) – SAVA Investment Management, a licensed fund…
Cleverbridge Appoints Dr. Markus A. Wesel as Its Chief Financial Officer
Cologne, Germany, Apr 3, 2023 – (ACN Newswire) – Cleverbridge is pleased to appoint Dr….
Bid on a Private Lunch With Ray Dalio to Help Support Financial Education for All Students
Helping the Council for Economic Education Build Life Skills Nationwide NEW YORK–(BUSINESS WIRE)–#CEE—Ray Dalio, New…
Tricia Breeger Named CEO of Mitsubishi Electric Power Products, Inc.
WARRENDALE, Pa.–(BUSINESS WIRE)–Mitsubishi Electric Power Products, Inc., (MEPPI) today announced current President Tricia Breeger as…
april Launches AI-Driven Tax Solution, Disrupting Archaic Tax System to Usher in a Consumer-Friendly Future
In partnership with Acorns, Mercury Financial, B9, Moves, and others april is embedding AI-powered tax…
Morgan Stanley Capital Partners Enters Agreement to Sell Ovation Fertility to US Fertility
NEW YORK–(BUSINESS WIRE)–Investment funds managed by Morgan Stanley Capital Partners (“MSCP”), the middle-market focused private…
INmune Bio, Inc. Announces Submission of Investigational New Drug (IND) Application for INKmune™ to the U.S. Food and Drug Administration for Treatment of Metastatic Castration-Resistant Prostate Cancer
BOCA RATON, Fla., April 03, 2023 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a…
INmune Bio, Inc. Announces Submission of Investigational New Drug (IND) Application for INKmune™ to the U.S. Food and Drug Administration for Treatment of Metastatic Castration-Resistant Prostate Cancer
BOCA RATON, Fla., April 03, 2023 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a…
Aerami Therapeutics to Host Virtual Investor Day with Leading Experts in Pulmonary Hypertension as AER-901 (Inhaled Imatinib) Advances Toward Phase 2
DURHAM, N.C., April 03, 2023 (GLOBE NEWSWIRE) — Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical…
Aerami Therapeutics to Host Virtual Investor Day with Leading Experts in Pulmonary Hypertension as AER-901 (Inhaled Imatinib) Advances Toward Phase 2
DURHAM, N.C., April 03, 2023 (GLOBE NEWSWIRE) — Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical…
Celularity Receives U.S. Food And Drug Administration (FDA) Preliminary Assessment For Celularity’s Investigational Fuse Bone Void Filler To Be Regulated As A Device By FDA’s Center For Devices And Radiological Health
Celularity’s Pre-Request for Designation (Pre-RFD) is based on data demonstrating 100 percent biochemical characterization of…
Celularity Receives U.S. Food And Drug Administration (FDA) Preliminary Assessment For Celularity’s Investigational Fuse Bone Void Filler To Be Regulated As A Device By FDA’s Center For Devices And Radiological Health
Celularity’s Pre-Request for Designation (Pre-RFD) is based on data demonstrating 100 percent biochemical characterization of…
Enochian BioSciences’ CEO Letter to Shareholders
Turning the Page; A Promising Future LOS ANGELES, April 03, 2023 (GLOBE NEWSWIRE) — (NASDAQ:…
Enochian BioSciences’ CEO Letter to Shareholders
Turning the Page; A Promising Future LOS ANGELES, April 03, 2023 (GLOBE NEWSWIRE) — (NASDAQ:…
Panbela Announces New Research Agreement with Johns Hopkins University School of Medicine
MINNEAPOLIS, April 03, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Panbela Announces New Research Agreement with Johns Hopkins University School of Medicine
MINNEAPOLIS, April 03, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…